Brief: Shah Capital Pushes For Novavax Sale
12/11/2025 21:19
Nov 12 (Reuters) - Shah Capital: SHAH CAPITAL: "NOVAVAX SHAREHOLDERS WILL BE BETTER SERVED UNDER THE UMBRELLA OF A LARGER, COMPETENT PHARMA COMPANY" SHAH CAPITAL: BOTH NOVAVAX BOARD AND TOP MANAGEMENT SHOULD TAKE ABOUT 50% PAY CUT SHAH CAPITAL: HAS ABOUT 8.3% SHAREHOLDING IN NOVAVAX Further company coverage: NVAX.O ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks